Ignite Creation Date:
2024-05-05 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00419094
Status:
COMPLETED
Last Update Posted:
2014-09-05
First Post:
2007-01-04
Brief Title:
Conversion to Monotherapy Study With Keppra XR for Partial Seizures
Sponsor:
UCB Pharma
Organization:
UCB Pharma
Organization Data
Organization:
UCB Pharma
Class:
INDUSTRY
Study ID:
N01280
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
UCB Pharma
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None